您的位置: 首页 > 农业专利 > 详情页

DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-ITM2A ANTIBODY
专利权人:
THE UNIVERSITY OF TOKYO
发明人:
ABURATANI, HIROYUKI,ISHIKAWA, SHUMPEI,KAWAI, SHIGETO
申请号:
EP12774392
公开号:
EP2700652A4
申请日:
2012.04.18
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
Disclosed is a monoclonal antibody binding to an ITM2A protein. This antibody is useful in the diagnosis, prevention, and treatment of cancer such as Ewings sarcoma, T cell leukemia, T cell lymphoma, acute myeloid leukemia, B cell tumor, and multiple myeloma. The present invention also provides a pharmaceutical composition, a cell growth inhibitor, and an anticancer agent containing the antibody as an active ingredient, and a method for treating cancer, a method for predicting the efficacy of cancer treatment, and a method for determining the presence of cancer in a test subject using the antibody.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充